Introduction of a remifentanil-based analgo-sedation protocol leads to a reduction of duration of mechanical ventilation and ICU stay in critically ill patients

Documenti analoghi

• Cost-consequence analysis of remifentanil-based analgo-sedation vs. conventional analgesia and sedation for patients on mechanical ventilation in the Netherlands
  di: Al, Maiwenn J, et al.
  Pubblicazione: (2010)
• Weaning from mechanical ventilation using remifentanil versus midazolam–morphine analgo sedation: our experience
  di: Nardo, M Di, et al.
  Pubblicazione: (2005)
• Remifentanil for postoperative analgo-sedation: effects on glycaemia and HOMA score
  di: Chelazzi, C, et al.
  Pubblicazione: (2010)
• Remifentanil-based analgesia and sedation is well tolerated when administered for up to 10 days in mechanically ventilated ICU patients
  di: Karabinis, A, et al.
  Pubblicazione: (2004)
• Economic evaluation of remifentanil-based versus conventional sedation for patients with an anticipated mechanical ventilation duration of 2–3 days in Germany
  di: Al, MJ, et al.
  Pubblicazione: (2008)